ABOUT US
Precision testing for all women
Proseek bio exists to close the diagnostic gap costing women their lives. Founded by Associate Professor Michelle Hill, we’re developing multi-biomarker blood tests that detect disease earlier, without adding complexity for labs or doctors.
We don’t just research and publish. We make sure they work in the real world through clinical studies and create quality reagent kit manufacturing processes, so our products are ready for immediate adoption by clinical laboratories. Our focus is on impact: improving accuracy, reducing diagnostic delay, and ensuring better health outcomes for women.
OUR VALUES
What drives us
Innovate with purpose
Every breakthrough must serve a real, urgent need.
Every breakthrough must serve a real,
Collaborate for impact
We work alongside clinicians, researchers, labs, and advocates to bring solutions into practice.
Connect with respect
We build lasting relationships through care, understanding, and mutual respect.
CORE TEAM
The scientists and leaders behind Proseek Bio
Assoc. Prof. Michelle Hill
Founder & CEO
25+ years in biomedical research and leadership in cancer biomarker development.
Co-Founder & Chief Commercial Officer
Dr Leo Bolero
Biotech commercialisation and regulatory strategy expert with a background in AI-driven medical informatics.
Dr Idris Mohd Najib
Product Development
Lead Scientist
Biomedical scientist specialising in translational research and diagnostic product development.
Dr Thomas Stoll
R&D Scientist
Analytical chemist with 20+ years in mass spectrometry, advancing diagnostic platform accuracy.
Jesse Henning
Production Scientist
Hands-on experience in manufacturing, quality control and R&D, with a background in COVID test manufacturing, ELISA testing and raw materials QC.
Dr Jessica Desport
Operations and Quality Manager
Deep science and translational R&D specialist, bridging laboratory innovation and clinical application.
Clinical & Regulatory Affairs Manager
Sahana Rajashekar
Clinical trial operations and project management specialist in MedTech.
Alejandra Guevara
Fractional Financial Compliance Officer
Financial compliance specialist advancing women's health through sound financial governance.
_edited.jpg)
Fractional General Counsel and Company Secretary
Katrina Bills
Legal counsel specialising in governance, legal strategy, and supporting high-growth companies
as they scale.
Fractional Marketing Lead
Sophia Sorensen
Specialist in translating complex health and science information into clear, compelling and human content.
BOARD
Our board of directors
Chair, Non-Executive Director
Jane Andrews
Non-executive director and entrepreneur with a passion for using innovation to generate impact.
Non-Executive Director
Peter Bradley
Diagnostics industry veteran and AusMedtech leader with deep expertise in regulatory and commercial strategy across the medtech sector.
Non-Executive Director
Andrew J Nash
Global executive with 35 years of experience. Public and private company CEO, President, CXO experience. Former Global Partner in Big 4 Consulting Firm.
